“KPV reduces gut inflammation”
targeted gut anti-inflammatory · NF-kB inhibition · PepT1 transporter
Some people report benefits and others describe concerns or side effects. Experiences vary, and none of this determined the verdict below.
While KPV shows potential for reducing gut inflammation in mice and human cell studies, it has not yet been proven to work in living humans. Laboratory research suggests KPV may block inflammatory signals like NF-kB and could be absorbed through the gut, but we lack clinical trials to confirm safety or effectiveness for conditions like IBD in humans.
- Human
- Moderate
- Animal
- Moderate
- Lab
- None
Research and educational information only. Not medical advice.